Pharmaceutical Technology on MSN
J&J’s Caplyta wins MDD approval to extend revenue horizonThe US Food and Drug Administration (FDA) has approved Caplyta as an adjunctive therapy with antidepressants for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results